TABLE 3

Inhibition assay results Values of the present study are mean ± S.E.


Substrate

Inhibitor

Mode of Inhibition

Ki Total

Ki Unbound
μM
Diclofenac Tolbutamide Competitive 59 ± 13 59
Diclofenac Ibuprofen Competitive 30 ± 2.3 30
Diclofenac Fluvastatin Noncompetitive 0.20 ± 0.015 0.12
Tolbutamide Diclofenac Competitive 6.0 ± 2.0 5.2
Ibuprofen Diclofenac Competitive 3.0 ± 0.2 2.6
Fluvastatin
Diclofenac
Competitive
16.0 ± 5.4
13.8